Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
Leukemias driven by chromosomal translocation of the mixed-lineage leukemia gene (MLL or KMT2A) are highly prevalent in pediatric oncology. The poor survival rate and lack of an effective targeted therapy for patients with MLL-rearranged (MLL-r) leukemias emphasize an urgent need for improved knowle...
Main Authors: | Anthony K. N. Chan, Chun-Wei Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2019.00081/full |
Similar Items
-
Targeting the Epigenetic Lesion in MLL-Rearranged Leukemia
by: Chen, Liying Michelle
Published: (2013) -
Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
by: Alexia Tsakaneli, et al.
Published: (2021-09-01) -
Congenital B-lymphoblastic leukemia with a cryptic MLL rearrangement and post-treatment evolution to mixed phenotype acute leukemia
by: Elizabeth Moschiano, et al.
Published: (2016-01-01) -
MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals
by: María Sol Brassesco, et al.
Published: (2009-01-01) -
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
by: Zizhen Feng, et al.
Published: (2016-03-01)